The Dutch Society for Endocrinology (NVE) and Thyroid Organization Netherlands (SON) to know what the medical consequences for patients who were suddenly without drugs, after the manufacturer of Synthroid Duotab unannounced and without the production line in Oss, Noord giving clear reasons -Brabant, ended.
Therefore approximately 350,000 thyroid patients in the Netherlands had a significant number of cases of acute steps to alternative means such as Euthyrox and Levothyrox. ,, In their composition, these agents almost similar, but in the blood of the patient may have been a lower or higher release of the thyroid hormone levothyroxine, "explains internist-endocrinologist Dr. Bruce Wolffenbuttel out. ,, This changed situation can have a negative impact on the well being of the user. "Wolffenbuttel is secretary of the Dutch Society for Endocrinology.
For director Rietje Meijer Thyroid Netherlands Organization research can already start within a few weeks. Quickly, according to her, clarity be provided about the effect that the Synthroid substitutes on blood values. Several thousand patients who values gradually already registered their 'conversion'.
The central question on which the study is wanted worded answer, says Dr. Wolffenbuttel: ,, Did the 'switch' to another, replacement thyroid hormone or may not affect the quality of life of thyroid patients? We would like the experience of patients learn how the risk of side effects can minimize "He agrees:. ,, This study is indeed the direct result of the loss of Synthroid manufacturing in Oss, whose patients are victims. "
The study conducted by the Dutch Institute for Health Services Research (NIVEL) and Pharmo Institute, in cooperation with general practitioners, internists, endocrinologists, and Synthroid users from around the country.
Wolffenbuttel hopes and expects that patients not too much hampered by the conversion of their regular medication to another agent. ,, Equally we realize that there is a group of 10-15 per cent in the total number of users of thyroid agents that keep health, even if they are correct. "
Manufacturer Aspen Pharmacare stopped early this year the activities in Oss (Noord-Brabant) and would still be working to resume it in Germany. Or this company ever going to deliver the drug Synthroid Duotab in various dosages is currently not clear.
By Editorial Telegraaf.nl/ René Steenhorst Photo: Reuters
Reactie plaatsen
Reacties